Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001013762-23-001303

Director acquired 342,980 shares (conversion)

  • Director returned 342,980 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Sturge Simon · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2023-10-01 Conversion : show line 1 in the form +342,980 342,980 D
2023-10-01 Returned to the company : show line 2 in the form −342,980 0 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-01 Conversion : show line 3 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG −10,196 0 D
Loading xslF345X05/ownership.xml…